OncoSil Medical enters final FDA review stage for HDE
OncoSil Medical (ASX:OSL) enters the final stage of FDA review for its OncoSil device HDE application.
OncoSil Medical (ASX:OSL) enters the final stage of FDA review for its OncoSil device HDE application.
Blockchain investigator ZachXBT has criticised the United Kingdom’s sanctions regime after compliance measures linked to HTX reportedly resulted in frozen funds and blocked transactions for some cryptocurrency users.
Native Mineral Resources (ASX:NMR) has poured a substantial gold dore bar at its project site.
NOVONIX (ASX:NVX) announced a major executive shake-up following the upcoming departure of its CFO.
oOh!media (ASX:OML) confirmed it is the target of a fresh, non-binding acquisition bid from global buyout firm Bain Capital and associated financial sponsors.
Solana’s recent 17% decline appears to reflect more than a routine market correction, with on-chain data showing capital leaving the ecosystem, long-term holders reducing exposure and trading activity weakening simultaneously.
Citrini Research, the investment research firm that drew attention earlier this year for warning about an artificial intelligence stock bubble, has highlighted Hyperliquid and its HYPE token as a compelling opportunity within the cryptocurrency sector.
Regener8 Resources (ASX:R8R) commenced its maiden soil sampling programme at the newly acquired Srebrenica North Project.
Humanity Protocol has suffered a major security breach after attackers reportedly stole more than $30 million worth of its native H token through a compromised private key, triggering a sharp collapse in the token’s price.
The Reserve Bank of Australia has released an analytical framework to address the growing threat of geopolitical risk to national financial stability.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas